Tag: HHS
The effective date for the 340B Drug Program Ceiling Price and Manufacturer Civil Monetary Penalties has been delayed once again, pushing the date to July 1, 2018. A Final Rule was released today, stating: HHS proposed this action to allow a more deliberate process of considering alternative and supplemental regulatory provisions and to allow for sufficient time…
Read MoreDevelop Your 340B Strategy
CiiTA has, through extensive experience, developed a set of best practices to help guide you through the creation of your 340B strategy. Download our process document to facilitate the development of your strategy.